Specific EGFR Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non–Small-Cell Lung Cancer Receiving First-Line Gefitinib Monotherapy Our results show that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results